Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
4.820
-0.220 (-4.37%)
At close: Sep 4, 2026, 4:00 PM EDT
4.845
+0.025 (0.52%)
After-hours: Sep 4, 2026, 7:54 PM EDT
Immuneering Market Cap
Immuneering has a market cap or net worth of $311.84 million as of September 4, 2026. Its market cap has increased by 39.69% in one year.
Market Cap
311.84M
Enterprise Value
132.80M
1-Year Change
39.69%
Ranking
Category
Stock Price
$4.82
ChartMarket Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $311.84M, a decrease of -14.76%. That is a compound annual growth rate of -3.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 311.84M | -26.60% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Upstream Bio | 329.17M |
| Vanda Pharmaceuticals | 328.31M |
| InflaRx | 327.16M |
| Sionna Therapeutics | 324.63M |
| Pyxis Oncology | 324.46M |
| Vicore Pharma Holding AB | 320.75M |
| Orchestra BioMed Holdings | 305.33M |
| Bicycle Therapeutics | 300.97M |